Real-time enrollment status for this fatty liver disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:54 AM UTC
| NCT Number | NCT06318169 |
| Recruiting Status | Recruiting |
| Condition | Fatty Liver Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,350 participants |
| Active Locations | 152 sites in the US |
| Sponsor | 89bio, Inc. |
| Last Updated on CT.gov | July 13, 2026 (5 days ago) |
As of July 18, 2026: Clinical trial NCT06318169 is currently recruiting participants. This phase3 study for fatty liver disease is actively seeking new participants at 152 locations across the United States. The study is sponsored by 89bio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06318169 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 152 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06318169 was last updated 5 days ago (July 13, 2026). HelloStudys verifies this status automatically.